Ambassador Ahmet Üzümcü, presented the case for The International Biotech Organization (IBTO) to the Biological Sub-Working Group of the Global Partnership Against the Spread of Weapons and Materials of Mass Destruction on October 6, 2022.
Tag: bio
Expert Reactions to the Updated U.S. Biodefense Strategy and Implementation Steps
Nolan Center experts examine the Biden Administration's new National Biodefense Strategy and Implementation Plan and its accompanying National Security Memorandum.
Event Summary: Building Capacities for Addressing Future Biological Threats
On September 20th, CSR hosted a webinar titled “Building Capacities for Addressing Future Biological Threats.” The webinar featured a keynote address from Dr. David Christian Hassell, followed by a panel discussion with Dr. Pardis Sabeti and Dr. Akhila Kosaraju.
Event Summary: The American Pandemic Preparedness Plan—One Year of Progress & The Path Forward
On September 8th, the Council on Strategic Risks (CSR) hosted a webinar entitled “The American Pandemic Preparedness Plan: One Year of Progress & The Path Forward.” The event was part of a broader engagement to introduce the 2022 Annual Report on the American Pandemic Preparedness Plan, which was released by the White House on September 1st.
Event: Building Capacities for Addressing Future Biological Threats
In this webinar, experts will discuss the changing biological threat landscape and some key avenues to improve preparedness and response capabilities for addressing future biological threats.
Outcomes of Biological Weapons Convention 2022 Consultative Meeting: No Countries Support Russia’s False Allegations
There is a real risk that BWC implementation could slow or stall by the end of this year. This is unacceptable given how biological risks are rising. It would also create an unacceptable dent in confidence in international cooperation for addressing the world's biggest systemic risks.
BRIEFER: 100 Days of Monkeypox: Evaluating the U.S. Response to the Emerging Global Outbreak
This Briefer details the early dynamics of the outbreak, evaluates the testing, vaccination, and therapeutic rollout, and provides an outlook and analysis meant to help the United States prevent and address similar biological threats.
Event: The American Pandemic Preparedness Plan: One Year of Progress & The Path Forward
In this webinar, Dr. Matthew Hepburn and Dr. Carly S. Cox will discuss the 2022 Annual Report on the American Pandemic Preparedness Plan, which was released on September 1st
The Ongoing Review of Dual-use Research Policy
This post highlights important recommendations on DURC to frame what outcomes we hope to see from the NSABB Review.
U.S. Health and Human Services Secretary Beccera to Give Preparedness and Response its Own Division
ASPR’s new elevated role would make it the lead agency for internal hiring, as well as deploying and working with the industrial base via purchasing contracts to prepare for strong responses to future infectious disease outbreaks.